Save your place

Sign in to WhoBought

Please try again later.

Ken Griffin's Journey Medical Corporation (DERM) position

Not anymore: Ken Griffin fully exited DERM in Q1 2026. The position peaked at an amount we cannot price in Q4 2021.
View full portfolio →
Value at exit
an amount we cannot price
Shares at exit
69K
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

DERM price vs Griffin's position

Dates
$6$6.5$7$7.5← Earlier —6 purchases
Average closing price · filing quarter
Price range · filing quarter

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q1 2026 Exited −69K −100.0% 0 May 15, 2026
Q4 2025 Added +55K +382.4% 69K Feb 17, 2026
Q3 2025 New +14K 14K Nov 14, 2025
Q1 2025 Added +5K +10.5% 49K May 15, 2025
Q4 2024 New +45K 45K Feb 14, 2025
Q4 2023 New +11K 11K Feb 14, 2024
Q4 2021 New +11K 11K Feb 14, 2022
Data through Q1 2026 · filed May 15, 2026
7 grouped rows from 7 quarters

More Griffin positions

Common questions

Does Ken Griffin own DERM?

Not currently. Ken Griffin fully exited DERM in Q1 2026, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Ken Griffin buy DERM?

Ken Griffin first disclosed a DERM position in Q4 2021; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Ken Griffin sell DERM?

Yes. Ken Griffin reduced and then fully exited DERM by Q1 2026; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of DERM does Ken Griffin own?

None as of the latest filing: Ken Griffin has exited DERM. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Ken Griffin pay for DERM?

Ken Griffin began building the DERM position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.